Six years after the world first learned of COVID-19, the pandemic has faded into an unpleasant memory for many. For others, however, it never fully ended. A long-term study by Hiroshima University has found that while lingering ...
10 hours ago
0
5
In almost half of all fatal electric scooter crashes in Sweden, the rider has been under the influence of alcohol. These fatal crashes occur mainly in the evenings or at night, and in all cases, no helmet was worn. This is ...
10 hours ago
0
1
A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new therapeutic approach that uses hydrogen peroxide (H₂O₂), a reactive oxygen species that damages cells ...
11 hours ago
0
5
For decades, lung disease has been the most visible and life-threatening part of cystic fibrosis. People might picture chronic (long-term) cough, breathlessness, recurrent chest infections and oxygen therapy.
11 hours ago
0
1
Nutritional imbalance during pregnancy can have long-lasting effects on the health and disease susceptibility of offspring. As such, high fructose intake through sweetened food and beverages in pregnant women has been associated ...
11 hours ago
0
1
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in Western countries. IHD arises when blood vessels of the heart become clogged, blunting oxygen and nutrient ...
11 hours ago
0
1
Psychological stress is increasingly recognized as a risk factor for certain health conditions, including cardiovascular disease and diabetes, especially when paired with an impaired immune response. In a study in Cell Stem ...
11 hours ago
0
3
A new study has found cannabidiol (medicinal cannabis) to be a promising treatment for several drug-resistant forms of pediatric epilepsy, offering renewed hope to families.
11 hours ago
0
2
A nationally representative Australian study published in The Lancet Global Health has found that vision impairment remains almost three times more prevalent among Indigenous Australians ages 50 and older than non-Indigenous ...
11 hours ago
0
1
A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B-cell-depleting therapy, is as effective as ocrelizumab in newly diagnosed relapsing multiple sclerosis ...
12 hours ago
0
3
